Our findings, particularly regarding THC, are important in the context of the ECS in MS, given reports demonstrating changes in the expression of endocannabinoids in CSF, lymphocytes [26] and plasma [27] of pwMS, while the expression of FAAH and CB2 is altered in whole blood of pwMS [27]. This evidence concerns the gene CNR2 and myeloid sarcoma.